| Item | Cat. No. | Application | Isotype |
| Anti-CD27 [LG.3A10] (MABL-3732) | MABL-3732 | Activating, IP, FC, IF | Engineer antibody |
| Anti-CD28 [E18] (MABL-3733) | MABL-3733 | immunosuppression, SPR, Block, FC, IHC | Engineer antibody |
| Anti-CD28 [D665] (MABL-3734) | MABL-3734 | CoStim, SPR, Superagonism, FC, IHC | Engineer antibody |
| Anti-CD40 [3/23] (MABL-3735) | MABL-3735 | IP, FC, IHC | Engineer antibody |
| Anti-CD40L (CD154) [MR1] (MABL-3736) | MABL-3736 | Blocking, functional assays, FC | Engineer antibody |
| Anti-CD70 [TAN 1-7] (MABL-3737) | MABL-3737 | Block, ELISA, FC, IF | Engineer antibody |
| Anti-CD70 [TAN1-6] (MABL-3738) | MABL-3738 | Blocking, WB, FC, IF | Engineer antibody |
| Anti-CD86 (B7-2) [PO3] (MABL-3739) | MABL-3739 | Blocking, functional assays, WB, FC, IHC | Engineer antibody |
| Anti-CTLA-4 [9H10] (MABL-3740) | MABL-3740 | Neutralisation, proliferation assays, WB, ELISA, FC | Engineer antibody |
| Anti-GITR [YGITR 860.103.5] (MABL-3741) | MABL-3741 | FC | Engineer antibody |
| Anti-GITR [YGITR765] (MABL-3742) | MABL-3742 | Block, FC | Engineer antibody |
| Anti-GITRL [YGL386] (MABL-3743) | MABL-3743 | ELISA, FC | Engineer antibody |
| Anti-ICOS [7E.17G9] (MABL-3744) | MABL-3744 | Block, FC | Engineer antibody |
| Anti-ICOSL [HK5.3] (MABL-3745) | MABL-3745 | Block, FC | Engineer antibody |
| Anti-OX40L [OX-89] (MABL-3746) | MABL-3746 | Blocking, FC, IHC-Fr | Engineer antibody |
| Anti-PD-1H (VISTA) [MH5A] (MABL-3747) | MABL-3747 | therapeutic, Block, ELISA, IHC | Engineer antibody |
| Anti-PD-L1 [YDC 127.1.1] (MABL-3748) | MABL-3748 | FC | Engineer antibody |
| Anti-PDPN (MAP-Tag) [PMab-1] (MABL-3749) | MABL-3749 | epitope tag, FACS, WB, Block, ELISA, FC, IHC | Engineer antibody |
| Anti-TIGIT [4D4] (MABL-3750) | MABL-3750 | agonist, FC | Engineer antibody |
| Anti-CD200 x CD47 [OX-90] (MABL-3751) | MABL-3751 | ELISA, FC, IHC | Engineer antibody |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
